Eukaryotic Translation Initiation Factor 2D (EIF2D) Peptide
EIF2D
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN940111
Aperçu rapide pour Eukaryotic Translation Initiation Factor 2D (EIF2D) Peptide (ABIN940111)
Antigène
EIF2D
(Eukaryotic Translation Initiation Factor 2D (EIF2D))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- KVTVVRNLEA YGLDPYSVAA ILQQRCQAST TVNPAPGAKD SLQVQIQGNQ
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LGTN antibody,
Alternative Names: Ligatin control peptide, Ligatin antibody Blocking Peptide, Anti-Ligatin Blocking Peptide, HCA56 Blocking Peptide, LGTN Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- EIF2D (Eukaryotic Translation Initiation Factor 2D (EIF2D))
-
Sujet
- LGTN is a protein receptor that localizes phosphoglycoproteins within endosomes and at the cell periphery. This trafficking receptor for phosphoglycoproteins may play a role in neuroplasticity by modulating cell-cell interactions, intracellular adhesion, and protein binding at membrane surfaces. In hippocampal neurons, long-lasting down-regulation of ligatin mRNA levels occurs via post-transcriptional RNA processing following glutamate receptor activation. This protein contains single PUA and SUI1 domains and these domains may function in RNA binding and translation initiation, respectively.
-
Poids moléculaire
- 65 kDa
Antigène
-
Vous êtes ici:
